RT

frankenfish
Reuters/Ki Price

Regulators with the FDA have released a preliminary report that suggests they will soon give the go-ahead to a team of scientists who’ve created a sci-fi “frankenfish.”

On Friday, the US Food and Drug Administration released an environmental assessment report regarding a salmon-hybrid developed in the laboratories of AquaBounty. The FDA must wait two months before they make final their decision regarding the fate of the frankenfish, but through their study they have determined that the genetically engineered animal, the “AquAdvantage,” is safe enough to be sold.

The fish, a hybrid of the Pacific Chinook salmon and a ray-finned creature called the eelpout, is engineered to grow twice as normal as traditional salmon. Once the frankenfish is approved for good, AquaBounty will be able to offer meatier fish able to feed more people. “In all other respects,” the company says the AquAdvantage fish is “identical to other Atlantic salmon.”

The AquAdvantage “will not have any significant impacts on the quality of the human environment of the United States,” the FDA wrote, noting additionally that the fish is unlikely to harm populations of natural salmon.

The FDA has 60 days to hear remarks from the public before it makes its final decision. At this point, though, experts weighing in with the Associated Press say the report suggests an approval is all but certain. From there, AquaBounty is likely to release what will be the first genetically engineered animal ever determined safe for human consumption. With no other such animal ever approved in the past, though, concerns have been plentiful over what consequences the creature could spawn.

Read More

1QDqvmvuqtb3KRLQcdxHrBoV8rvt6nnnnv

If you enjoy reading the information we bring you, please consider donating to WTF News via Bitcoin. Any donations are appreciated and go directly to expanding our capabilities.